Furthermore, a recent clinical study reported that the expression level of Notch1, Notch3, and JAG-1, one of the Notch ligands, were inversely correlated with the overall clinical outcomes in breast cancer patients [11]. The gene discussed is NOTCH1; the disease is breast cancer.